Get early access! Join the Twelve Data AI Assistant waitlist now.

VICO

OMX
Market closed
Access this stock data via API
Subscribe
Vicore Pharma Holding AB
0
0
0%

Financials

Income statement

Fiscal date Mar 2025 Dec 2024 Sep 2024 Jun 2024
Total reported revenue 892K 5.1M 0 0
Cost of revenue
Gross profit 892K 5.1M 0 0
Operating expense
Research & development 78.7M 81.6M 49.5M 50.0M
Selling general and admin 14.1M 17.0M 10.9M 12.7M
Other operating expenses -417K 631K -218K 404K
Operating income -91.5M -94.1M -60.1M -63.1M
Non operating interest income
Income 6.4M 10.0M 3.5M 6.7M
Expense 26.4M 1K 3.3M 5K
Other income expense
Pretax income -111.5M -84.1M -60.0M -56.4M
Tax provision 0 0 -64K -96K
Net income -111.5M -84.1M -59.9M -56.3M
Basic EPS -0.5 -0.4 -0.5 -0.5
Diluted EPS -0.5 -0.4 -0.5 -0.5
Basic average shares 234.6M 216.1M 111.7M 114.8M
Diluted average shares 234.6M 216.1M 111.7M 114.8M
EBITDA -85.1M -84.1M -56.7M -56.4M
Net income from continuing op. -91.5M -94.1M -60.1M -63.1M
Minority interests
Preferred stock dividends 0 0 0 0
Market closed

Exchange is currently closed (non-working day)
Main market opens in 1 day 10 hours 12 minutes

22:47
00:00
23:59

Trading Hours (Monday - Friday):

Main market
09:00 - 17:30
All times are displayed in the Europe/Stockholm timezone (CEST, UTC+02:00).